We are working to change the world with the first universal influenza vaccine.
Chief inventor and researcher of InvVax's breakthrough vaccine technology.
Biochemist and accomplished life science product development leader with deep experience from research through commercialization.
Strong experience with early-stage companies, especially commercializing technologies from universities.
An investor specializing in bio-technology and current chair of the Life Sciences for Sand Hill Angels.
Financial and operational experience from early stage high tech to large multi-national enterprises.
One of world's leading structural biologists with specialization in influenza and other viruses.
Expert in university technology transfer and commercialization, and financing early-stage biotech companies.
Expert on vaccine commercialization, Professor chair of "International Public Health and the Pharmaceutical Industry".
35 years of experience in biological process development, expert in vaccine development & commercialization.
Nonclinical toxicology consultant with extensive experience in biologics and vaccine development.
Director of the UCLA Center for AIDS Research (CFAR), known for his innovative work on the AIDS virus (HIV).